• AAPL 189.82
  • TSLA 177.46
  • AMZN 184.7
  • MSFT 420.21
  • INTC 31.85
  • EURUSD 1.0872
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. JK /
  3. BBNI.JK

Bank Negara Indonesia Tbk (BBNI JK) stock market data APIs

Rp5200 -25(-0.5%) as of May 17, 2024

Bank Negara Indonesia Tbk Financial Data Overview

5225
5200
-
5275
5125
4115.8113-5975
192 756 320 M
9.1723
579 M
48 585 488 M
143
0.0539
0.918
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BBNI',
Type: 'Common Stock',
Name: 'Bank Negara Indonesia Tbk',
Exchange: 'JK',
CurrencyCode: 'IDR',
CurrencyName: 'Indonesian Rupiah',
CurrencySymbol: 'Rp',
CountryName: 'Indonesia',
CountryISO: 'ID',
OpenFigi: NULL,
ISIN: 'ID1000096605',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: '1996-11-25',
InternationalDomestic: 'International',
Sector: 'Financial Services',
Industry: 'Banks - Regional',
}

Bank Negara Indonesia Tbk Fundamental Data is available in our Financial Data APIs

  • Net Revenue 48 585 488 M
  • EBITDA 0
  • Earnings Per Share 564.2
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Bank Negara Indonesia Tbk Earnings via APIs

  • Latest Release 2024-04-30
  • EPS/Forecast 146.8

Get Bank Negara Indonesia Tbk End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Bank Negara Indonesia Tbk latest news via APIs

SSMS Plantation Holdings Pte. Ltd. -- Moody's downgrades Sawit Sumbermas to Caa1; outlook remains negative

Rating Action: Moody's downgrades Sawit Sumbermas to Caa1; outlook remains negativeGlobal Credit Research - 11 Jan 2022Singapore, January 11, 2022 -- Moody's Investors Service has downgraded the corpo...
  • CREDIT RATING
  • CREDIT RATINGS
  • CREDIT RESEARCH
  • MOODY'S
  • MOODY'S INVESTORS SERVICE
  • MOODY'S RATING
  • SSMS

Akero Therapeutics Presents Analyses at the 2021 International Liver Congress Showing Normalization of Liver Fat Substantially Reduced Markers of Liver Injury and Fibrosis, and Greatly Increased Probability of Resolving NASH

Analyses also Show that Combining a Threshold for ALT Reduction of ≥17 U/L with Normalization of Liver Fat Improves Predictive Power for Resolution of NASH with 1-Stage Improvement of Fibrosis SOUT...
  • AKERO THERAPEUTICS
  • CLINICAL TRIAL
  • CLINICAL TRIALS
  • IMPROVEMENTS
  • LIVER FAT
  • LIVER FAT CONTENT
  • NASH
  • NORMALIZATION
  • TREATMENT OF NASH
Do you have any questions?
support@eodhistoricaldata.com